generics

At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Flag link:
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Yahoo/Reuters
patents
Novo Nordisk
generics
Wegovy
Ozempic
Flag link:
Generics maker VistaPharm recalls ulcer med on bacteria contamination fears
Generics maker VistaPharm recalls ulcer med on bacteria contamination fears
Fierce Pharma
VistaPharm
product recalls
generics
Flag link:
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Takeda
generics
gout
Colcrys
antitrust
Flag link:
The fading generics industry and essential medicine supply
The fading generics industry and essential medicine supply
Pharmaphorum
generics
supply chain
drug shortages
Flag link:
Despite price drops, J&J gets little reprieve from TB drug saga
Despite price drops, J&J gets little reprieve from TB drug saga
Medical Marketing and Media
JNJ
tuberculosis
generics
bedaquiline
Flag link:
Novartis updates on Sandoz finances ahead of spin-off
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Novartis
Sandoz
spinoffs
generics
biosimilars
Flag link:
Teva to Pay $225M in DOJ Generic Drug Price-Fixing Settlement
Teva to Pay $225M in DOJ Generic Drug Price-Fixing Settlement
BioSpace
Teva Pharmaceutical
DOJ
price fixing
legal
generics
Flag link:
Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Biopharma Reporter
Novartis
Sandoz
spinoff
biosimilars
generics
Flag link:
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Novartis
Sandoz
spinoffs
generics
biosimilars
Flag link:
Sandoz plans to enter the Eylea biosimilar race
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration
Flag link:
Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster
Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster
BioSpace
Pfizer
generics
legal
Vyndamax
heart disease
patents
tafamidis
Dexcel Pharma
Flag link:
Eliquis: the cardio drug that cannot be beat
Eliquis: the cardio drug that cannot be beat
EP Vantage
Bristol Myers Squibb
Eliquis
generics
Flag link:
In win for generics industry, Viatris wards off $50M payment in tax battle with IRS
In win for generics industry, Viatris wards off $50M payment in tax battle with IRS
Fierce Pharma
Viatris
IRS
taxes
patents
generics
Flag link:
Gilead, Teva prevail in high-stakes trial over HIV drug pay-for-delay claims
Gilead, Teva prevail in high-stakes trial over HIV drug pay-for-delay claims
Fierce Pharma
Gilead Sciences
Teva Pharmaceutical
HIV
pay-for-delay
generics
legal
Flag link:
Sanofi blocks Sandoz's Jevtana generic in patent win
Sanofi blocks Sandoz's Jevtana generic in patent win
Fierce Pharma
Sanofi
Jevtana
generics
Sandoz
prostate cancer
legal
Flag link:
Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Medical Marketing and Media
generics
cancer
drug shortages
ADHD
antibiotics
Cisplatin
carboplatin
Flag link:
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Novartis
Sandoz
generics
biosimilars
Flag link:
US Military Is So Worried About Drug Safety It Wants to Test Widely Used Medicines
US Military Is So Worried About Drug Safety It Wants to Test Widely Used Medicines
Bloomberg
Valisure
generics
Department of Defense
Flag link:
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
Fierce Pharma
JNJ
schizophrenia
generics
Trinza
Viatris
Flag link:

Pages